Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the structural heart devices market grown over the years?
The market size of structural heart devices has seen robust growth in the past years. It is predicted to increase from $10.41 billion in 2024 to $11.44 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.9%. The impressive growth during the historic period was driven by factors such as the shift towards less invasive surgical methods, increased demand for minimally invasive structural heart devices, continuous training and educational initiatives for healthcare professionals, an upsurge in healthcare spending, and the growing preference of patients for non-surgical or minimally invasive treatment alternatives.
What Is the forecasted market size and growth rate for the structural heart devices market?
The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $16.48 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, timely regulatory approvals for new structural heart devices. Major trends in the forecast period include increasing adoption of transcatheter valve replacement, ongoing development of innovative devices with advanced materials, growing emphasis on personalized treatment approaches, increasing adoption of hybrid procedures, integration of remote monitoring and telehealth solutions.
Get your structural heart devices market report here!
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report
What are the major factors driving growth in the structural heart devices market?
The escalating occurrence of cardiovascular disorders is projected to stimulate the expansion of the structural heart device market. Cardiovascular conditions, including coronary artery disease, heart attacks, and strokes, all part of a collection of disorders affecting the heart and blood vessels. Sedentary lifestyles, unhealthy dietary practices, increasing obesity numbers, smoking, and aging populations have all contributed to the growing global prevalence of these diseases. These conditions are treated with structural heart devices, which rehabilitate or replace damaged heart valves, rectify structural flaws, and enhance the function of the heart and patient outcomes. For instance, data released by the UK-based British Heart Foundation demonstrated that approximately 7.6 million people in the UK have heart and circulatory diseases, with males constituting around 4 million and females about 3.6 million. Roughly 27% of total UK deaths are a result of these diseases, amounting to over 170,000 deaths yearly, or close to 480 deaths daily, which translates to one death every three minutes. Therefore, the existing trend of growing cardiovascular disease incidents is invigorating the expansion of the structural heart device market.
What key areas define the segmentation of the global structural heart devices Market?
The structural heart devices market covered in this report is segmented –
1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems
2) By Procedure: Replacement Procedures, Repair Procedures
3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications
4) By Age Group: Pediatric, Adults
Subsegments:
1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings
2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings
3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders
4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp
Who are the key players steering the development of the structural heart devices market?
Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.
What are the key trends shaping the future of the structural heart devices market?
Key industry players in the structural heart devices market are innovating and creating minimally invasive therapeutic procedures and instruments in order to advance patient results, reduce the healing period, and broaden treatment possibilities for structural heart diseases. A self-expanding transcatheter aortic valve implantation (TAVI) system, a type of device intended to position and fasten the substitute valve inside the original aortic valve anatomy, does not require balloon inflation. For example, Abbott Laboratories, a medical devices and health care products manufacturing firm based in the US, introduced the Navitor, its newest-generation TAVI system, in India in December 2022. Geared towards people with severe aortic stenosis who face substantial or extreme surgical risk, it incorporates innovations such as a distinct design to circumvent valve leakage. Navitor not only augments Abbott’s structural heart transcatheter collection but also provides doctors and patients with minimally invasive alternatives for managing heart diseases. It is unique in being the only self-expanding TAVI system with intra-annular leaflets and large frame cells, thereby improving access to coronary arteries for potential upcoming interventions concerning coronary artery disease (CAD). The new design further optimizes hemodynamics by bolstering blood flow.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15677
Which regions are emerging as leaders in the structural heart devices market?
North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Heart Pump Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report
Implantable Heart Pacemaker Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report
Prosthetic Heart Valve Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
